We Are Hiring
Sung Wan Kim Endowed Chair in Drug and Gene Delivery
The University of Utah College of Pharmacy seeks excellent, diverse applicants for the Sung Wan Kim Chair in Drug and Gene Delivery in the Department of Molecular Pharmaceutics at the Associate Professor or Full Professor level. The Sung Wan Kim Chair in Drug and Gene Delivery is supported by an endowment honoring Dr. Sung Wan Kim, a pioneer in drug delivery and biomaterials research who was Distinguished Professor of Molecular Pharmaceutics and Distinguished Professor of Biomedical Engineering until his untimely passing in 2020. Dr. Kim’s intent for the endowment was to support a leader in drug and gene delivery. Eligible candidates will have a Ph.D. and/or M.D., with a sustained record of peer reviewed funding, distinguished international reputation, and a substantial research and publication record in any of the following fields – drug and gene delivery, nanomedicine, gene therapy, molecular imaging and theranostics, biomedical engineering, immunology, cell biology, chemistry, biochemistry, or related fields. Opportunities exist for the successful candidates to align research areas with campus-wide initiatives such as immunology, inflammation and infectious diseases, diabetes and metabolism, neuroscience, genomic medicine, chemical biology, and cancer. The Department and the University of Utah offer unparalleled opportunities for interdisciplinary collaborations and actively encourage translational research with clinicians and scientists in the Health Sciences Center and the Huntsman Cancer Institute. Candidates must also be committed to teaching excellence in subjects relevant to both graduate (PhD) and professional (PharmD) programs in the College of Pharmacy. The preferred areas include but are not limited to drug and gene delivery, nanomedicine, gene therapy, molecular imaging, theranostics, immunology, cell biology, chemistry, and biochemistry.
The award of the Sung Wan Kim Chair in Drug and Gene Delivery will be made upon the recommendation of the Chair of the Department of Molecular Pharmaceutics and a search committee of the Department (Chair: Dr. Kopeček; Members: Drs. Goel, Lim, Mauger, and Yu).
Tenure-track joint faculty position with Molecular Pharmaceutics and Biomedical Engineering
The Department of Molecular Pharmaceutics (PHCEU, formerly the Department of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy) (https://pharmacy.utah.edu/pharmaceutics/) and the Department of Biomedical Engineering (BME, College of Engineering) (https://www.bme.utah.edu/glance/) at the University of Utah seek excellent, diverse applicants for a tenure-track joint faculty position across all ranks.
Potential areas of research interests include, but are not limited to, microbiome engineering, tumor-based infection, immunotherapy, neurotherapeutics, cell therapy, interfaces of modern pharmaceutics and data science, synthetic biology, and innovative biomaterials for gene and drug delivery.
We seek candidates with expertise at the interface of the missions of both departments and preferably aligned with pillars of excellence in the University of Utah Health Sciences and the Huntsman Cancer Institute. These include initiatives in neuroscience, cancer, diabetes and metabolism, and immunology, inflammation, and infectious diseases. Translational alliances with the University’s Cardiovascular Research and Training Institute (CVRTI), the Huntsman Mental Health Institute, and/or the Health Sciences Bioinformatics cluster are other possibilities.